Medical News

RSS

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

Disparities in major leg amputation and mortality for patients with diabetic foot ulcers

A new study published in JAMA Network Open aimed to identify how intersectionality among race, ethnicity, rurality, and neighborhood disadvantage can result in high risks of major leg amputations and death among Medicare beneficiaries who were hospitalized with diabetic foot ulcers.

24 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

A new study describes a novel COVID-19 detection technique based on T-cell receptor sequencing.

24 Apr 2022

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

A new study discusses the potential of certain plant compounds to block SARS-CoV-2 replication within host cells.

24 Apr 2022

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Researchers estimate the effectiveness of primary vaccination and a booster dose in people with and without prior SARS-CoV-2 infection.

24 Apr 2022

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Researchers explore how the presence of SARS-CoV-2 RNA in feces can be associated with the presentation of GI symptoms.

24 Apr 2022

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Anti-N antibodies may have lower sensitivity in mRNA-1273-vaccinated individuals who were previously infected with SARS-CoV-2.

24 Apr 2022

Study highlights a rapidly increasing patient population with long COVID and lack of treatments

A new UK study of more than 2,000 patients after hospitalization with COVID-19 presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Respiratory Medicine shows that, one year after having COVID-19, only around one in four patients feel fully well again.

24 Apr 2022

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global Health, shows that giving a different type of vaccine (heterologous) for the third or 'booster' dose than was received for the first two doses, leads to better vaccine performance than using the same (homologous) inactivated SARS-CoV-2 vaccine for all three doses.

24 Apr 2022

Research identifies inadequate PPE management in COVID-19 testing centers as source of major cross-contamination

Lack of glove changes at COVID-19 testing centers in Belgium led to major cross-contamination of samples and a high rate of false positive results, research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April) has found.

24 Apr 2022

C. difficile study finds the sharing of multiple antibiotic-resistance genes between pigs and humans

A study investigating samples of the superbug Clostridioides difficile across 14 pig farms in Denmark finds the sharing of multiple antibiotic-resistance genes between pigs and human patients, providing evidence that that animal to human (zoonotic) transmission is possible.

24 Apr 2022

Study determines how much U.S. hospitals mark up the price of cancer therapies

U.S. spending on cancer therapies has risen sharply in recent years. Researchers from Brigham and Women's Hospital analyzed data on drug pricing from 61 National Cancer Institute-designated cancer centers to determine how much U.S. hospitals mark up the price of cancer therapies for patients with private health insurance.

24 Apr 2022

Research identifies the third day of hospitalization as a tipping point in progression of COVID-19 pneumonia

New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April), has identified the third day of hospitalization as a tipping point in the progression of disease among symptomatic patients admitted for COVID-19 pneumonia.

23 Apr 2022

Disease-causing amoebas that live on organic leafy vegetables could be a threat to public health

New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that disease-causing amoebas that live on organic leafy vegetables can shelter human pathogens like Pseudomonas, Salmonella, and Helicobacter and are a potential risk to public health.

23 Apr 2022

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

High levels of respiratory pathogens are present in the air of nurseries, schools, nursing homes and other indoor settings during winter, according to new research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April).

23 Apr 2022

Researchers identify cytokines that can help predict negative outcomes in COVID-19 patients

New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April) has identified a panel of cytokines that can help predict which COVID-19 patients are at risk of serious illness and death.

23 Apr 2022

Study: A considerable number of healthcare workers took sick leave after COVID-19 vaccination

A third of healthcare workers took sick leave after being vaccinated against COVID-19, a German study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April) has found.

23 Apr 2022

COVID-19 vaccine protection against omicron wanes over time, study shows

A study released April 22 in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants. However, against omicron, this protection wanes over time - even after a third dose.

23 Apr 2022

Video radiology reports can be a valuable tool to help patients better understand imaging test results

Video radiology reports—created for individual patients using easy-to-understand language and clearly annotated images—can be valuable tools to help patients better understand test results, according to a new study published online April 20 in the American Journal of Roentgenology.

22 Apr 2022

Medical News

Monoclonal-antibody combination AZD7442 prevents COVID-19

Disparities in major leg amputation and mortality for patients with diabetic foot ulcers

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Study highlights a rapidly increasing patient population with long COVID and lack of treatments

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

Research identifies inadequate PPE management in COVID-19 testing centers as source of major cross-contamination

C. difficile study finds the sharing of multiple antibiotic-resistance genes between pigs and humans

Study determines how much U.S. hospitals mark up the price of cancer therapies

Research identifies the third day of hospitalization as a tipping point in progression of COVID-19 pneumonia

Disease-causing amoebas that live on organic leafy vegetables could be a threat to public health

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

Researchers identify cytokines that can help predict negative outcomes in COVID-19 patients

Study: A considerable number of healthcare workers took sick leave after COVID-19 vaccination

COVID-19 vaccine protection against omicron wanes over time, study shows

Video radiology reports can be a valuable tool to help patients better understand imaging test results

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News